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Abstract
This paper summarises the discussion during the 
workshop on ‘Overdiagnosis and overtreatment of 
infectious diseases in general practice. How and 
where to break the endless loop?’ The workshop was 
organised as part of the overdiagnosis conference 
carried out in August 2018 in Copenhagen, 
Denmark. During the workshop, participants from 
all over the world reflected on the challenges of 
embracing the overdiagnosis paradigm as a tool 
to advance understanding and to find solutions 
to the unnecessary use of antibiotics in primary 
health care. It was concluded that the narrow view 
of the overdiagnosis paradigm does not provide 
theoretical resources to address the problem of the 
inherent connection between diagnostic error and 
treatment decision. In contrast to the overdiagnosis 
paradigm, the too much medicine paradigm is 
an umbrella term suitable to frame actions that 
recognise the complexity of the decision-making 
process during the consultation and its impact on 
overtreatment.
Introduction
Unnecessary and excessive use of antibiotics is the 
main driver of antimicrobial resistance.1 The pros-
pect of patients dying from common infections 
caused by multiresistant bacteria in the long term 
is grim unless the situation is reversed by limiting 
the use of antibiotics only to patients in whom the 
benefits outweigh the harms.
Since the publication of the book ‘Overdiag-
nosed: Making People Sick in the Pursuit of Health’ 
by Welch et al in 20112 and the launching of the 
first International conference on overdiagnosis 
in 2013, overdiagnosis has become a widely used 
term to address the drivers of ‘too much medicine’.
Well-defined concepts are essential to advance 
understanding and to find concrete solutions to a 
problem. In that sense, Brodersen et al published 
a paper about what is and is not overdiagnosis.3 
In this paper, overdiagnosis is defined as the diag-
nosis of a condition, that would otherwise not 
cause symptoms or harm to a patient during his or 
her lifetime’. They go further by arguing that terms 
such as overtesting, misdiagnosis and false-posi-
tives do not belong to the overdiagnosis paradigm.
This assertion has raised more questions than 
answers within the clinical and research area 
regarding infectious diseases and the use of anti-
biotics. In this paper, we summarise the main 
points discussed during the workshop ‘Overdi-
agnosis and overtreatment of infectious diseases 
in general practice. How and where to break the 
endless loop?’.4 During the workshop, participants 
from all over the world reflected on the challenges 
of embracing the overdiagnosis paradigm as a tool 
to advance understanding and to find solutions 
to the unnecessary use of antibiotics in primary 
healthcare.
It was concluded that the current definition 
of overdiagnosis is not suitable and falls short 
of addressing the complexity of the drivers and 
consequences of excessive and unnecessary use 
of antibiotics. On the contrary, the ‘too much 
medicine’ paradigm5 gives space for a broader 
understanding of overdiagnosis as errors during 
the diagnostic process, which are inherently 
connected to the error in the treatment decision 
called overtreatment.
Overdiagnosis versus ‘too much medicine’
The current definition of overdiagnosis is based 
on long-term or chronic conditions and asympto-
matic patients. It markedly differs from the type of 
population managed in primary healthcare due to 
a suspected acute infectious disease.
First of all, all the patients seeking care at 
primary healthcare have atypical or typical symp-
toms, a type of perceived change that triggers the 
need for seeking healthcare. Second, the focus 
of benefits against harms is mostly driven by 
outweighing the benefit of shortening the length 
of time with symptoms against the harms due to 
the development of adverse effects including the 
development of antimicrobial resistance.6 7
Therefore, neither the overdiagnosis of an 
asymptomatic patient nor the development of 
unforeseen long-term harms is the main problem 
regarding the diagnosis and subsequent manage-
ment of patients with a suspected acute infection.
The main problem is the interplay of multilevel 
factors that influence the diagnostic process and 
treatment decision, which leads to overtreatment.8 
From this perspective, the ‘too much medicine’ 
paradigm is an umbrella term that gives room for 
recognising the singularities of each error while 
reminding us that they are part of a bigger picture.
Looking for solutions to the unnecessary 
use of antibiotics is far from being an easy 
task. Determinants and actions targeting diag-
nostic errors influence the treatment decision 
and vice versa. Understanding the components 
of the bigger picture and the challenges of the 
diagnostic errors within the ‘too much medicine’ 
paradigm are crucial to bringing about effective 
solutions.
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The bigger picture
Worldwide, the patient–doctor encounter in primary care faces 
similar challenges such as (a) short consultation time, (b) high 
uncertainty of the origin of the symptoms, (c) uncertainty of 
the evolution of symptoms and (d) organisational challenges for 
following the patient.9 10
During the patient–doctor encounter, patients’ expectations 
and general practitioners’ (GP) attitudes toward these expectations 
are drivers of ‘too much medicine’. As mentioned above, there 
are typical and atypical symptoms that trigger an active search 
for healthcare. Patients/the family expect something from their 
GP. It can include a check-up, reassurance, a medical certificate, 
antibiotic therapy or simply guidance on symptom management.
GPs who perceive high patient expectations for antibiotics are 
more likely to prescribe antibiotics (ie, overtreatment)  unneces-
sarily. A recent study in Australia found that more than half of the 
GPs included in the study self-reported that they would prescribe 
antibiotics for an upper respiratory tract infection to meet patient 
expectations.11 However, while all patients are believed to expect 
something, only some patients expect antibiotics, and among 
these patients, a subset demands antibiotics. Notwithstanding, 
patient expectations may be based on false assumptions, with 
many overestimating the effectiveness of antibiotic treatment.12
It is very important for GPs to meet patients’ expectations, as it 
is a way to preserve a good doctor–patient relationship. Prescribing 
increases patient satisfaction and reinforces the doctor–patient 
relationship as clinicians often feel prescribing as less stressful 
than an anxious patient or parent.13 Some clinicians do not feel 
that it is worth jeopardising their relationship with a patient or 
parent over a relatively minor matter of prescribing antibiotics. 
The consequences for the future relationship with patients are 
more of a concern for GPs prescribing antibiotics than antibiotic 
resistance.9 GPs are generally aware of and concerned about the 
threat that antimicrobial resistance poses and agree that this is a 
growing problem. However, antimicrobial resistance is considered 
more of a public health issue, whereas the GPs’ priority is to be 
responsive to the needs of the individual patient.
This example shows the multidimensional factors that play a 
role in the decision whether to prescribe antibiotics. There is a 
patient expecting a solution to his/her problems. There is a GP 
expecting to be responsive to the needs of the patient. There is a 
system expecting a rational use of resources and contention of the 
antimicrobial resistance problem.
The challenges of the diagnostic errors
Mislabelling or misdefinition,14 not considered as overdiagnosis 
under the definition of overdiagnosis of Brodersen et al, is an 
error during the diagnostic process. However, it is difficult to 
know whether mislabelling lead to overtreatment or vice versa. 
Due to the short time of the consultation in primary care, it is 
difficult to determine the logical order of the decision taken by the 
GP. Sometimes a GP mislabels the patient with another diagnosis 
to better justify the administration of antibiotic therapy, for which 
treatment is unnecessary. A clear example is the differentiation of 
a sore throat into two different labels (pharyngitis and tonsillitis). 
Patients are diagnosed with tonsillitis if the clinicians intend to 
treat a sore throat with antibiotics and they use the milder cate-
gory of pharyngitis if they think that the infection has a viral 
cause. In extreme cases, GPs decide to prescribe antibiotics even 
before examining the patient.15 It goes against logical thinking as 
treatment should be the subsequent step after a systematic diag-
nostic process.
It implies that the current system to assess overtreatment is 
quite inaccurate. Future research should focus on finding better 
ways to assess overtreatment and the extent of mislabelling. For 
example, the assessment should be based on the presence of diag-
nostic information (eg, cluster of signs and symptoms, results of 
rapid tests) as well as prognostic criteria (eg, age and comorbidi-
ties) rather than the label given by the prescriber.
Other examples of the broader vision of errors in the diag-
nostic process connected to the decision to treat are overtesting 
and misinterpretation of diagnostic information (ie, false  posi-
tives). These terms are not considered as overdiagnosis under the 
Brodersen et al definition of overdiagnosis.
Currently, there is no single item of the diagnostic information 
(eg, signs, symptoms  and results of rapid tests) able to predict 
whether an infection has a viral or a bacterial origin with 100% 
certainty. Systematic reviews about the diagnostic accuracy of 
signs and symptoms for the most common infections managed 
in primary care16 17 have shown that the specificity of signs and 
symptoms is low. The cluster of symptoms like the Centor crite-
ria—used to predict the bacterial origin of a sore throat18—or 
the cluster of symptoms to identify patients with influenza-like 
symptoms,19 who can benefit from early antiretroviral therapy can 
increase predictive accuracy, but it depends on the prevalence of 
the disease.20 Thus, a treatment decision only based on signs and 
symptoms is likely to yield a high proportion of false-positives, 
resulting in overtreatment.
The use of rapid tests has been advocated as a solution to 
increase diagnostic accuracy, thereby decreasing overtreatment.21 
However, the introduction of this technology in primary care is in 
its infancy with a lot of controversy about the added value.22 23
Models to understand the factors influencing the proper use 
and added value of rapid testing in primary care have demon-
strated a complex interaction between availability, interpretation 
and easy-to-use factors.24
Currently, rapid tests to support the diagnostic process in 
patients with a suspected infection seeking help in primary care 
are available in very few countries. In most of the world, the deci-
sion of whether to prescribe antibiotics is taken based only on 
signs and symptoms.
One of the few countries with the wide availability of rapid 
tests is Denmark. This scenario allowed us to assess the use of 
diagnostic tools in daily practice and its effect on treatment deci-
sion in patients with suspected urinary tract infection (UTI).25 We 
found that in 85% of the patients with a suspected uncompli-
cated UTI, urine culture was part of the diagnostic process. Many 
international guidelines recommend the use of urine culture only 
in patients with suspected complicated UTI; then this 85% could 
be regarded as overtesting. However, overtreatment was lower in 
the group of patients in which urine culture was performed in 
comparison with the group of patients in which antibiotics were 
prescribed based only on signs and symptoms. To disentangle the 
causal path between the use of rapid test and overtreatment is not 
straightforward. Thus, there is a growing awareness about the fact 
that the assessment of the causal pathway between the use of a 
rapid test and the effect on overtreatment needs re-structuring. 
The field of diagnostic test evaluation requires further develop-
ment and operationalisation of variables within the ‘too much 
medicine’ paradigm if the rapid tests are to become systematically 
introduce in primary healthcare worldwide.
Conclusion
Overall, it can be seen that the overdiagnosis paradigm is unre-
lated to these multidimensional factors. The type of population, as 
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well as the dilemmas regarding benefits and harms in the manage-
ment of patients with suspected infections, differ in crucial aspects 
of the population and dilemmas covered by the overdiagnosis 
paradigm. The umbrella term of too much medicine is broader and 
allows the use of theories and strategies without getting trapped 
into the dilemmas of trying to squeeze the multidimensional 
factors of diagnostic error and overtreatment into the narrow defi-
nition of what is and is not overdiagnosis.
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